New Strategic Partnership with Leading Danish CRO

COBO Technologies and BioXpedia Join Forces to Develop CRISPR QC Platform for Future Gene Therapies

COBO Technologies and BioXpedia partner to develop and advance a new platform for QC analysis of CRISPR-edited cells. This platform is aimed at supporting the clinical development of future therapies using gene-editing tools such as CRISPR.

Read the full press release here.